OOSB yields 12.05% · MRK yields 2.81%● Live data
📍 MRK pulled ahead of the other in Year 8
Combined, OOSB + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of OOSB + MRK for your $10,000?
OOSB provides exposure to the S&P 500 and Bitcoin. The fund aims for long-term capital appreciation by using leverage through US-listed futures, pooled investment vehicles, and collateral. The fund targets 100% notional exposure for the returns of each component or an aggregate of 200%. The strategy seeks to magnify exposure so that every $1 investment is $1 exposure each to the S&P 500 and Bitcoin. The fund does not invest directly in Bitcoin but uses Bitcoin price reflected in the next or second-to-next expiring futures contract. In the case of other Bitcoin-linked investments, value is calculated by the average. Through a wholly owned Cayman Islands subsidiary, the fund invests in futures, ETPs with similar exposure, equities, and cash and cash equivalents. The actively managed ETF has full discretion to adjust the portfolio at any given time, while maintaining its tax status. Therefore, tracking deviation may be greater than the performance of the S&P 500 or Bitcoin.
Full OOSB Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.